Apyx medical corporation announces new debt facility with perceptive advisors

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that the company and its subsidiaries have entered into a new, five-year credit agreement with perceptive credit holdings iv, lp (“perceptive”), an affiliate of perceptive advisors. the perceptive credit agreement provides for a facility of up to $45 million in senior secured term.
APYX Ratings Summary
APYX Quant Ranking